Trademark: 79154002
Word
GWPHARM
Status
Dead
Status Code
604
Status Date
Tuesday, October 13, 2015
Serial Number
79154002
Mark Type
4000
Filing Date
Thursday, June 5, 2014
Published for Opposition
Tuesday, February 17, 2015
Abandoned Date
Tuesday, October 13, 2015

Trademark Owner History
GW Pharma Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes
GW PHARMACEUTICALS

Trademark Events
Nov 20, 2021
New Representative At Ib Received
Dec 21, 2017
New Representative At Ib Received
Oct 28, 2016
Final Decision Transaction Processed By Ib
Oct 13, 2016
Final Disposition Notice Sent To Ib
Oct 13, 2016
Final Disposition Notice Created, To Be Sent To Ib
Oct 13, 2015
Abandonment Notice Mailed - Inter Partes Decision
Oct 13, 2015
Abandonment - After Inter Partes Decision
Oct 13, 2015
Opposition Terminated No. 999999
Oct 13, 2015
Opposition Sustained No. 999999
Jun 19, 2015
Change Of Name/Address Rec'd From Ib
Apr 24, 2015
Refusal Processed By Ib
Mar 23, 2015
Opposition Instituted No. 999999
Mar 20, 2015
Opposition Notice (Ib Refusal) Sent To Ib
Mar 20, 2015
Opposition Notice (Ib Refusal) Created
Mar 19, 2015
Opposition Papers Received At Ttab
Feb 17, 2015
Official Gazette Publication Confirmation E-Mailed
Feb 17, 2015
Published For Opposition
Feb 14, 2015
Notification Processed By Ib
Jan 28, 2015
Notification Of Possible Opposition Sent To Ib
Jan 28, 2015
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 28, 2015
Notification Of Notice Of Publication E-Mailed
Jan 14, 2015
Law Office Publication Review Completed
Jan 14, 2015
Assigned To Lie
Jan 12, 2015
Assigned To Lie
Jan 12, 2015
Assigned To Lie
Dec 21, 2014
Approved For Pub - Principal Register
Nov 25, 2014
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 25, 2014
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 22, 2014
Teas/Email Correspondence Entered
Nov 22, 2014
Correspondence Received In Law Office
Nov 22, 2014
Teas Response To Office Action Received
Nov 21, 2014
Refusal Processed By Ib
Nov 8, 2014
Application Filing Receipt Mailed
Nov 6, 2014
Non-Final Action Mailed - Refusal Sent To Ib
Nov 6, 2014
Refusal Processed By Mpu
Nov 5, 2014
Non-Final Action (Ib Refusal) Prepared For Review
Nov 4, 2014
Non-Final Action Written
Nov 4, 2014
Assigned To Examiner
Nov 4, 2014
New Application Office Supplied Data Entered In Tram
Oct 30, 2014
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24